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Background: Studies have reported that heparin may be unsuitable as an anticoagulant in human plasma samples
when quantifying cytokines using multiplex bead array assays. For mouse samples, multiplex assays have been
validated for serum and EDTA-plasma, but it remains to be elucidated whether heparin influences the quantification
of cytokines, and if so – to what extent. Furthermore, laboratory mice are often anesthetized for blood sampling,
which causes acute stress that may influence circulating cytokine concentrations and thus bias experimental results.
The objectives of the present study were to identify whether specific cytokine concentrations varied between
heparin-plasma, serum, and EDTA-plasma, and whether short isoflurane anesthesia would influence the concentrations
of these cytokines in the circulation. Twenty-three acute phase and pro-inflammatory cytokines were quantified in
matched serum, EDTA-plasma, and heparin-plasma samples from anesthetized and unanesthetized male NMRI mice
using a multiplex assay. In addition, samples from unanesthetized mice were spiked with three levels of heparin.
Results: The concentrations of five out of 23 cytokines were significantly different between sample types, but only one
cytokine (IL-17A) differed between heparin-plasma and serum. When further spiking the heparin-plasma with increasing
concentrations of heparin, there was a significant effect on 11 cytokines, where the cytokine recovery could be
correlated to the heparin concentration for ten of these cytokines. Anesthesia resulted in lower concentrations
of G-CSF, but had no significant impact on the concentrations of the other 22 cytokines.
Conclusion: In mice, heparin seems like a suitable anticoagulant for obtaining plasma for multiplex assays for
the cytokines IL-1α, IL-1β, IL-2, IL-6, IL-9, IL-12p40, IL-12p70, IL-13, G-CSF, GM-CSF, IFN-γ, KC, MCP-1, MIP-1α, MIP-1β,
RANTES and TNFα, but an effect of heparin in high concentrations should be considered for the cytokines IL-9, IL-12p40,
IL-12p70, KC, MCP-1, MIP-1β and RANTES. Short isoflurane anesthesia had significant impact on G-CSF, but none of the
other cytokines.
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Multiplex bead array assays (MBAA) allow simultaneous
quantification of multiple analytes from small blood samples
[1-4], which is ideal for laboratory rodents that yield small
sample volumes for analysis. In mice, MBAA can be used
with serum and EDTA-plasma (manufacturer’s instructions).
Heparin is a commonly used anticoagulant in mouse experi-
mentation, but it may absorb certain cytokines [5,6], leading
to erroneously low measurements. Some studies on human* Correspondence: annete@sund.ku.dk
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unless otherwise stated.samples have investigated this effect [7,8]. Biancotto et al.
[9] performed an extensive study comparing 72 analytes in
human serum and plasma samples, using heparin, citrate
and EDTA as anticoagulants. Although the mouse is the
most widely used laboratory animal [10], and heparin is
probably the most widely used anticoagulant, the heparin-
effect on cytokines in mouse blood samples has not been
systematically investigated. The present study was designed
to investigate the effect of heparin on the quantifications of
cytokines in mouse plasma.
Furthermore, heparin may be used not only as coating
on tubes for the collection of blood samples, but in many
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ferent concentrations are used in flushing solutions. In the
rather new technology of automated blood sampling
[14-16], heparin is regularly infused in low concentrations
to maintain catheter patency. Therefore, it was relevant to
study, whether heparin in increasing concentrations would
influence the accuracy of measuring circulating levels of
cytokines.
Blood samples are often obtained from anesthetized ani-
mals, and anesthesia, even without surgery, may elicit an
acute stress response [17,18] with increased release of glu-
cocorticoids and catecholamines to the circulation [19,20].
The concentrations of some cytokines in the circulation
may be affected by catecholamines and glucocorticoids,
and the modulation of cytokines in different animal spe-
cies caused by chronic stress has been evaluated [21-24].
However, it remains unknown if acute transient stress in-
fluences the concentrations of cytokines. As many labora-
tory animals are anesthetized for blood sampling it was
important to investigate the effect of anesthesia on the
quantification of cytokines.
The aims of the present study were: 1) to investigate
the utility of heparin-plasma in MBAA for the quantifi-
cation of cytokines in mouse samples in comparison
with serum and EDTA-plasma, 2) to investigate whether
heparin in increasing concentrations would influence the
detection of cytokines and 3) to assess whether short
term isoflurane anesthesia would affect cytokine levels.
Aims 1 and 3 were sought explained in Experiment 1,
where a panel of 23 acute phase and pro-inflammatory
cytokines were quantified in matched serum, EDTA-plasma
and heparin-plasma samples from male NMRI mice. It was
hypothesized that the concentrations measured in heparin-
ized plasma would not be significantly different from those
measured in serum and EDTA-plasma for most cytokines,
and that isoflurane anesthesia would have no impact on the
concentration of these cytokines.
Aim 2 was sought explained in Experiment 2, where
the same 23 cytokines were compared in matched
serum, EDTA-plasma and heparin-plasma samples from
male NMRI mice, where three different concentrations of
heparin were studied. It was hypothesized that the con-
centrations of these cytokines, measured in all three levels
of heparinized plasma would not be significantly different
from those measured in serum and EDTA-plasma for
most cytokines.
Materials and methods
This experiment was approved by The Animal Experi-
ments Inspectorate under the Danish Ministry of Food,
Agriculture and Fisheries (license number: 2012/561-169).
The animals were handled by trained personnel in accord-
ance with the Guide for the Care and Use of Laboratory
Animals [25] in a fully AAALAC accredited facility.Animals
In total, 24 outbred male mice (BomTac:NMRI), aged six to
eight weeks, were purchased from Taconic (Ry, Denmark).
The use of an outbred mouse strain was chosen to create a
robust data set, based on a genetically heterogeneous group
of mice. Fourteen mice were used in Experiment 1 and ten
mice in Experiment 2. To avoid hormonal influences from
the estrous cycle, only male mice were used. A sample size
of five to seven animals per group was considered adequate
as estimated by a power analysis [26,27] of data from a pilot
study, with α and β levels set at 0.05 and 0.80, respectively,
and where an estimated mean difference in the concen-
trations of cytokines between serum, EDTA-plasma and
heparin-plasma exceeding 40% was considered biologically
relevant.
Housing
Upon arrival at the facility, the mice were housed in
groups of five or seven in Makrolon type II cages
(Tecniplast, Buguggiate, Italy) in an individually venti-
lated cage (IVC) system and allowed to acclimatize for
two weeks before experimentation. Aspen chips (Tapvei
Oy., Kortteinen, Finland) were used as bedding material.
Bite bricks (Tapvet®, Kortteinen, Finland), Enviro-dri®
nesting materials (Shepherd Specialty papers, Quakertown,
Pennsylvania, USA) and cardboard houses (Brogaarden,
Gentofte, Denmark) were used for environmental enrich-
ment. A diurnal rhythm was maintained with a 12:12 hour
light–dark cycle with artificial light from 06:00 am. Cage
temperature was kept at 22°C, relative humidity at 55% ±
10%, and the air changes were 75 times per hour.
Experimental procedure
Experiment 1
Fourteen mice were randomly divided into two groups;
with seven mice in a control group (NO_ANE) and
seven mice in a group subjected to isoflurane anesthesia
(ANE).
To avoid the blood sampling procedure itself contribut-
ing to a systemic stress response, the mice in the NO_ANE
group were concussed and exsanguinated through decapi-
tation within 30 seconds from being lifted out of the cage.
The total blood obtained per mouse was collected in three
tubes; one 1.5 ml microcentrifuge tube for serum, one
EDTA-coated tube (BD Microtainer; BD Inc., Franklin
Lakes, USA) for plasma and one heparin-coated tube (BD
Microtainer; BD Inc.) for plasma. The tubes were collected
in random order. One mouse in this group was excluded
from the analysis due to an insufficient volume of blood
collected, resulting in a total of six mice in the NO_ANE
group.
The seven mice in the ANE group were individually sub-
jected to isoflurane anesthesia for five minutes and allowed
to recover from the anesthesia before blood sampling.
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5% isoflurane delivered in 100% oxygen. Once the mouse
was in surgical anesthesia, isoflurane was turned down to
1-2% isoflurane in 100% oxygen. After five minutes, the
mouse was transferred to a clean cage in isolation from
cage mates. Blood samples were obtained in the same way
as described for the NO_ANE group twenty minutes after
the mice had regained their righting reflex.
Experiment 2
Ten mice were concussed and exsanguinated within
30 seconds from being lifted out of their cages, as de-
scribed for Experiment 1. The blood from each mouse
was collected in five tubes; one uncoated microcentri-
fuge tube for serum (“serum”), one EDTA-coated tube
(“EDTA”; BD Microtainer; BD Inc.) for plasma and
three heparin-coated tubes (BD Microtainer; BD Inc.)
for plasma. The heparin-coated tubes were either non-
spiked (“Hep”), or spiked with1 μl (“Hep1”) or 10 μl
(“Hep10”) of 5000 IU/ml heparin (Amgros IS, Copenhagen,
Denmark), respectively. The volumes of added heparin were
based on heparin concentrations (5–50 IU/ml) often used in
flushing solutions for catheters [28-30]. As the levels of five
cytokines in Experiment 1 were below the standard curve
and due to general low physiological concentrations of the
cytokines, the samples in Experiment 2 were spiked with
10 μl of a cytokine standard (Bio-Plex Pro Mouse Cytokine
Standard, Lot #5025850, Bio-Rad Laboratories, Copenhagen,
Denmark), containing a known concentration of the 23 cy-
tokines that were to be measured. The standard was added
undiluted to each sample; resulting in a total volume of
130 μl. Samples were spiked with heparin and cytokine stan-
dards immediately prior to analysis.
Analysis
After blood collection, serum samples were allowed to
coagulate at room temperature for 45 min, centrifuged
at 1,000 × g for 15 minutes and then at 10,000 × g for
ten minutes. Serum was then transferred to clean
tubes. Heparin and EDTA samples were centrifuged dir-
ectly and plasma was isolated. The samples were stored
at −80°C for maximally three weeks until analysis.
Thirty minutes prior to analysis, samples and assay re-
agents were equilibrated to room temperature. The sam-
ples were run at a 1:4 dilution and quantified in duplicate
using a 23-plex mouse panel for the quantification of
IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10,
IL-12p40, IL-12p70, IL-13, IL-17A, Eotaxin, G-CSF,
GM-CSF, IFN-γ, KC, MCP-1, MIP-α, MIP-β, RANTES
and TNF-α (Bio-Plex Pro assays, Bio-Rad Laboratories)
on a Luminex Bio-Plex 200 System (Bio-Rad Laboratories).
A nine point standard dilution series and all assay reagents
were prepared according to the manufacturer’s instruc-
tions. The standard curve was calculated for each cytokineby the software as a best fit five-point logistic regression.
The lower limit of quantification (LLOQ) was calculated as
two standard deviations above the levels measured in the
zero samples on the standard curve. The upper limit of
quantification (ULOQ) was defined as the highest standard
point in the standard curve with an intra-assay coefficient
of variation (%CV) of less than 20% and with a recovery
value within 70%–130%. The assay working range was thus
bounded by the LLOQ and ULOQ. The principle is based
on a sandwich ELISA, in which capture antibodies that are
coupled to fluorescently dyed microspheres (beads) bind the
biomarker of interest. The beads have distinct color codes
and spectral addresses for precise discrimination by a laser
flow cytometer. The detection antibodies produce a reporter
signal, which is then detected by the reader and the concen-
tration of bound analyte is registered by the software. The
system was set to count a minimum of 50 beads of each type
in each well, and the number of counted beads per sample
was registered to ensure that the analysis had run properly.
To verify that isoflurane anesthesia induced a stress re-
sponse in the mice of the ANE group in Experiment 1,
the samples were analyzed for serum and plasma cor-
ticosterone using a competitive ELISA (EIA 4164; DRG
Instruments GmbH, Marburg, Germany).
Data treatment and statistics
All data were analyzed in SPSS Statistics 20 (IBM,
Armonk, NY, USA) testing for normality using Shapiro-
Wilk tests on original data and log-transformed data. In
cases of normally distributed data, repeated measures
ANOVA (with Greenhouse-Geisser corrections, where ap-
propriate) with Bonferroni’s post hoc tests were performed
for all cytokines to compare group means and to test for
possible interactions between sample types and stress. In
cases of non-normally distributed data, Friedman tests
with Wilcoxon-signed rank post hoc tests were con-
ducted. Furthermore, a Mann–Whitney U test was used
to compare the concentrations of relevant cytokines be-
tween the anesthetized and unanesthetized groups (statis-
tics are presented in Table 1 and Table 2).
Serum and plasma corticosterone levels in Experiment
1 were analyzed for a significant difference between the
NO_ANE and ANE group using an independent samples
t-test. Statistics are presented as t(df ), where df is the
degrees of freedom. P-values < 0.05 were considered
significant.
In Experiment 2, a large variation within the Hep1
group was found. Because of the risk of erroneously not
detecting a significant difference in cytokine concentra-
tion between serum, heparin-plasma and EDTA-plasma
due to variation (type II error), the Hep1 group was ex-
cluded from the repeated measures ANOVA. As three
levels of heparin were required for the regression analyses
and as these analyses did not measure differences between
Table 1 Statistics of Experiment 1
Cytokine Distr. N (NO_ANE/ANE) Anova (p) Fried Wilc.-sign. rank Mann Whit. Conclusion
S H E Sample ANE As. p S-H S-E H-E As. p Sample (p) ANE (p)
IL-1α Log 5/7 5/7 5/6 0.018 0.113 S < E (0.033) NS
IL-1β Log 5/7 5/7 5/7 0.392 0.772 NS NS
IL-2 NND 6/7 6/7 6/6 0.482 0.418 NS NS
IL-6 NND 6/7 6/7 6/6 0.081 0,167 NS NS
IL-9 Log 5/7 5/7 5/7 0.440 0.963 NS NS
IL-12p40 Log 5/7 5/7 5/7 0.192 0.124 NS NS
IL-12p70 NND 6/7 6/6 6/6 0.241 0.280 NS NS
IL-13 NND 6/7 6/7 6/6 0.746 0.824 NS NS
IL-17A* NND 6/7 6/7 6/6 0.013 0.143 0.915 0.070 0.218 H < E < S* NS
G-CSF Log 5/7 5/7 5/7 0.194 0.016 NS NO_ANE > ANE
GM-CSF ND 5/7 5/7 5/7 0.174 0.923 NS NS
IFN-γ ND 5/4 5/4 5/4 0.495 0.700 NS NS
KC NND 6/7 6/7 6/6 0.002 0.699 0.003 0.015 0.929 S < E, H < E NS
MCP-1 Log 4/7 4/7 4/7 0.015 0.736 H < E (0.002) NS
MIP-1α ND 5/7 5/7 5/7 0.769 0.777 NS NS
MIP-1β NND 6/7 6/7 6/6 0.789 0.670 NS NS
RANTES NND 6/7 6/7 6/6 0.001 0.130 0.005 0.230 0.614 S < E NS
TNF-α NND 6/7 6/7 6/6 0.138 0.669 NS NS
Shown are the data distributions of the 18 measured that were above the detection limit cytokines for the sample types (Sample) serum (S), heparin-plasma (H)
and EDTA-plasma (E) and for the effect of isoflurane anesthesia (ANE): normal distribution (ND), log-normal distribution (Log) and non-normal distribution (NND),
and the number (N) of samples in each group (NO_ANE /ANE). P-values and asymptotic significances of a repeated measured ANOVA, Friedman test, Wilcoxon-signed
rank test and Mann Whitney test are given with significant differences highlighted in bold type. The conclusion states, for each cytokine, the difference between sample
types, or whether no significant differences (NS) were found. Where significant differences were found the sample types are listed in increasing order based on their
mean values. *IL-17A showed an overall significant difference in the Friedman test but not in the Wilcoxon-signed rank post hoc test, why the mean rank of the
anticoagulant groups are listed in increasing order. Five cytokines (IL-3, IL-4, IL-5, IL-10 and Eotaxin) were below the detection limit and were therefore not
included in the analysis.
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ponential regressions. Where a significant difference be-
tween heparin and serum was found, data were analyzed
for a correlation between the concentration of the analyte
and the amount of heparin added. Using the standard
addition method, the amount of heparin in the coating of
the tubes was estimated. Adding the median of the calcu-
lated values of heparin (21.14 μl) to the three levels (Hep =
0 μl, Hep1 = 1 μl, Hep10 = 10 μl) of heparin in the samples,
theoretical concentrations of heparin in all samples could
be obtained. These data were then subjected to linear
([Cyt] =B +A ×X) and exponential Cyt½  ¼ y0e −KXð Þ
 
regression analyses (presented in Table 3).Results
Experiment 1
The concentrations of five cytokines (IL-3, IL-4, IL-5,
IL-10 and Eotaxin) were below the detection limit for all
sample types, leaving 18 cytokines for further analysis
(see Additional file 1).
The concentrations were not significantly different be-
tween serum, EDTA-plasma and heparin-plasma for 13of the remaining 18 cytokines: IL-1β; IL-2; IL-6; IL-9;
IL-12p40; IL-12p70; IL-13; G-CSF, GM-CSF; IFN-γ;
MIP-1α; MIP-1β and TNF-α. The concentration of five
cytokines (IL-1α, KC, MCP-1, RANTES and IL-17A)
differed significantly between sample types (Table 1), where
serum contained higher concentrations than EDTA-
plasma for the cytokines IL-1α, KC and RANTES and
heparinized plasma contained higher concentrations than
EDTA-plasma for the cytokines KC, IL-17A and MCP-1.
Thus, the concentration of only one cytokine, IL-17A, was
different between heparin and serum. IL-17A showed an
overall significant difference in the Friedman test but not
in the Wilcoxon-signed rank post hoc test. Therefore, the
mean ranks of groups are listed in increasing order.
There were no significant differences for any of the
cytokine levels between anesthetized and control mice, ex-
cept for one cytokine. The NO_ANE group was found to
have higher G-CSF levels compared to the ANE group.
No interaction between sample types and anesthesia was
observed for any of the cytokines.
As corticosterone levels did not differ significantly be-
tween heparin-plasma, EDTA-plasma and serum in a one-
way ANOVA (F(2.30) = 0.646, P = 0.532), these levels were
Table 2 Statistics of Experiment 2
A Anova Conclusion
Cytokine Distr. Sample (p) (p)
IL-1α ND 0.536 NS
IL-1β ND 0.119 NS
IL-2 ND 0.845 NS
IL-3 ND 0.090 NS
IL-6 ND 0.379 NS
IL-9 ND 0.001 S > H (0.030), S > H10(0.000)
IL-10 ND 0.016 S > H (0.002), S > H10 (0.002)
IL-12p40 ND 0.007 S > H (0.004), S > H10 (0.001)
IL-12p70 ND 0.013 S > H10 (0.003)
Eotaxin ND 0.001 S > H(0.007), S > H10(0.014)
G-CSF ND 0.105 NS
IFN-γ ND 0.130 NS
KC ND 0.003 S > H(0.000),S > H10(0.000),H < E(0.034),H10 < E(0.031)
MCP-1 ND 0.007 S > H(0.001),S > H10(0.000),H > H10(0.042),H10 < E(0.043)
MIP-1α ND 0.050 NS
MIP-1β ND 0.003 S > H(0.015), S > H10(0.003), H < E(0.042),H10 < E(0.023)
RANTES ND 0.034 S > H10(0.018)
TNF-α ND 0.053 NS
B Fried. Wilc. sign. rank Conclusion (p)
Cytokine Distr. A. Sign. S-H S-H10 S-E H-H10 H-E H10-E
IL-13 NND 0.029 0.398 0.866 0.028 0.327 0.018 0.028 S < E, H < E, H10 < E
IL-17A NND 0.007 0.063 0.028 0.046 0.327 0.043 0.018 S > H10, S < E, H < E, H10 < E
Shown are the data distributions of the 20 measured cytokines that were within detection limits for the sample types (Sample) serum (S), heparin-plasma (H),
heparin-plasma added 10 μl heparin (H10) and EDTA-plasma (E), showing if data were normally (ND) or non-normally distributed (NND). The number of samples
was 5–6 in each group. P-values and asymptotic significances of a repeated measured ANOVA (Table 2A) or Friedman test (Fried.) with a Wilcoxon-signed rank test
(Table 2B) are given with significant values highlighted in bold type. The conclusion is shown for each cytokine, where NS signifies no significant difference
between sample types. Where significant differences were found the sample types are listed in increasing or decreasing order based on their mean values. Three
cytokines (IL-4, IL-5 and GM-CSF) were above the detection limit and were not included in the analysis.
Table 3 Statistics for the regression analyses
Linear regression Exponential regression














IL-9 0.48 0.23 0.008 −163.46 7.7 × 10−3 0.39 0.15 0.035 −0.04 5.6
IL-10 0.40 0.16 0.027 −97.15 7.6 × 10−3 0.56 0.32 0.001 −0.02 7.7
IL-12p40 0.87 0.76 0.000 −317.36 12.0 × 10−3 0.87 0.76 0.000 −0.05 12.0
IL-12p70 0.71 0.50 0.000 −379.48 19.0 × 10−3 0.74 0.54 0.000 −0.03 20.0
IL-17A 0.38 0.15 0.037 −266.41 18.5 × 10−3 0.11 0.01 0.547 −0.01 12.7
Eotaxin 0.65 0.42 0.000 −438.07 18.0 × 10−3 0.74 0.55 0.000 −0.05 19.0
KC 0.83 0.70 0.000 −960.63 27.0 × 10−3 0.91 0.83 0.000 −0.16 26.0
MCP-1 0.91 0.83 0.000 −156.83 6.0 × 10−3 0.91 0.82 0.000 −0.05 6.4
MIP-1β 0.74 0.55 0.000 −278.96 11.0 × 10−3 0.47 0.22 0.009 −0.04 7.6
RANTES 0.72 0.52 0.000 −20.70 0.9 × 10−3 0.65 0.42 0.000 −0.04 0.8
For cytokines that were significantly different between serum and heparin, the data were analyzed for a correlation between the concentration of the analyte and
the amount of heparin added; R, R2, p-values, slopes (A) and intercepts (B) for the linear regressions and intercepts (y0) and coefficients (K) for the exponential
regressions are given. The calculations are based on the addition of 1 μl or 10 μl heparin (5,000 IU/ml). Where significant, the relationship between the specific
cytokine concentration (pg/ml) and heparin (X) volume (μl) can be described as [Cyt] = B + A × X or Cyt½  = y0 e −KXð Þ :
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sterone levels were significantly higher in the ANE group
compared to the NO_ANE group (t(15.216) = −6.466, P <
0.001), as shown in Figure 1.
Experiment 2
Three analytes (IL-4, IL-5 and GM-CSF) were out of
range above the standard curve for all sample types;
hence 20 cytokines were left for further analysis (see
Additional file 2).
The concentrations were not significantly different be-
tween serum, EDTA-plasma and heparin-plasma for nine
cytokines: IL-1α, IL-1β, IL-2, IL-3, IL-6, G-CSF, IFN-γ
MIP-1α, and TNF-α (Table 2). The concentrations of 11
cytokines differed significantly between sample types, of
which the concentrations of ten cytokines (IL-9, IL-10, IL-
12p40, IL-12p70, IL-17A, Eotaxin, KC, MCP-1, Mip-1β
and RANTES) were significantly different between hep-
arin and serum and consequently further analyzed with
linear and exponential regression analyses. IL-13 differed
significantly between serum and EDTA-plasma but not
between serum and heparin-plasma, why this cytokine
was not subjected to regression analysis. It was found that
the concentrations of these ten cytokines could be linearly
related to the amount of heparin added to the samples.
An exponential relationship could also be fitted to all of
these cytokines with the exception of IL-17A, which could
be explained through linear regression only (Table 3).
Discussion
The 23 analytes measured in the present study were a
panel of cytokines, chemokines and growth factors thatFigure 1 Corticosterone levels. Shown are the corticosterone levels in bl
control mice (NO_ANE, n = 6). Data are presented as means ± SEM for pool
levels were significantly higher in anesthetized animals than in control animmay be used as biomarkers of both acute and chronic
immunologic pathologies [31,32] and may thus be rele-
vant for most researchers that study cytokines in mice.
In Experiment 1, we analyzed physiological levels of
cytokines from anesthetized and unanesthetized mice.
As these mice did not suffer from any infections or
other pathological conditions that could stimulate an
immune response, all cytokine concentrations were, as
expected, low. Higher serum cytokines levels have been
described in mice [33]. However, this study differed from
the present study with regard to study design, mouse
strain and the type of multiplex assay used. Thus the
studies are difficult to compare, as cytokine levels may
vary between strains [34] and between multiplex assays
from different companies [4].
In order to investigate the influence of heparin on
higher levels of cytokines, the samples in Experiment 2
were spiked with cytokine standards to reflect e.g. disease
states, where circulating cytokine levels are expected to be
elevated.
The first aim of the study was to investigate the utility
of heparin-plasma in MBAA for the detection of cyto-
kines in mouse samples in comparison to serum and
EDTA-plasma. Heparin is a negatively charged glycos-
aminoglycan that binds many proteins and cytokines
and is for this reason used in e.g. microdialysis as an af-
finity agent to capture certain cytokines [6]. The binding
properties of heparin depend on several factors like the
conformation of the specific cytokine in relation to the
binding site and the electrostatic interaction between
heparin and the cytokine [35]. Although several human
studies have investigated the heparin-binding propertiesood samples from anesthetized (ANE, n = 7) and unanesthetized
ed heparin-plasma, EDTA-plasma and serum samples. Corticosterone
als (P < 0.001).
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between animal species and thus the effect of heparin on
cytokine quantification may likewise vary between hu-
man and mouse samples.
In Experiment 1, we found no significant differences
between heparin-plasma and serum for the cytokines
IL-1α, IL-1β, IL-2, IL-6, IL-9, IL-12p40, IL-12p70, IL-13,
G-CSF, GM-CSF, IFN-γ, KC, MCP-1, MIP-1α, MIP-1β,
RANTES and TNFα. An effect of heparin was found for
only one cytokine, IL-17A. EDTA-plasma was significantly
different from serum with regards to four cytokines; IL-
1α, IL-17A, KC and RANTES. Thus, in the present study
where cytokines were quantified in low concentrations,
heparin was suitable as an anticoagulant for obtaining
plasma for cytokine analysis for most of the cytokines,
where an effect of EDTA was found to a larger extent.
The second aim of the study was to investigate whether
heparin in increasing concentrations would influence the
detection of cytokines. In Experiment 2, it was found that
the concentrations of the ten cytokines affected by added
heparin could be linearly related to the amount of heparin
added to the samples. However, using the linear or expo-
nential relationships and the volume of heparin added to
the sample to estimate the circulating concentration of a
specific cytokine in a sample is not advisable due to poor
fit of the regressions. Used cautiously, however, linear re-
gression for MCP-1, KC, IL-12p40 and IL-12p70 can be
used to obtain rough estimates of corresponding serum
concentrations, as these cytokines were better described
by their regressions than the others. Thus, in experimental
settings where heparin may be used in different concen-
trations to e.g. prevent clotting of catheters, an effect of the
added heparin should be expected for certain cytokines.
In the study by Biancotto et al. [9], 72 cytokines were
investigated of which 23 were also measured in the
present study. Overall the studies are in agreement, with
the exception of IL-17A, where we found an effect of
heparin in contrast with Biancotto et al. [9] who did not,
and IL-9, where both studies found an effect of heparin,
but the heparin effect was seen in the present study only
in Experiment 2, where higher concentrations of heparin
were used. Interestingly, although IL-6 has been shown
to bind to heparin [8], neither Biancotto et al. [9] or the
present study could find a statistically significant differ-
ence in the concentrations of IL-6 between the sample
types. Also in agreement, Biancotto et al. [9] found sig-
nificant differences between EDTA-plasma and serum
for several cytokines. It should be noted that if serum is
regarded as the golden standard, an effect of not only
heparin, but also EDTA should be accounted for regard-
ing certain cytokines, as demonstrated in the present
study and by Biancotto et al. [9].
The binding properties of heparin is, as stated previ-
ously, not fully investigated in mice. In addition to thepresent study, more studies testing the applicability of
heparin as an anticoagulant in blood samples for cyto-
kine quantification in different mouse strains and across
gender are still needed.
The third aim was to assess whether short term isoflur-
ane anesthesia would influence the cytokine levels in the
samples. Only the concentrations of one cytokine, G-CSF,
differed significantly between control mice and mice sub-
jected to short isoflurane anesthesia, where the concentra-
tions of G-CSF were lower in anesthetized mice.
After a stressful stimulus, the body releases glucocorti-
coids to the circulation, of which corticosterone is the
major effector hormone in rodents [36,37]. Anesthesia is
a potent inducer of the hypothalamic-pituitary-adrenal
(HPA) axis, and isoflurane anesthesia without surgery
has been shown to result in elevated serum cortico-
sterone levels in mice, peaking within five minutes of the
mice having gained their righting reflex and lasting for
up to four hours post-procedure [17,18,38]. Based on
these findings, corticosterone levels were expected to be
higher in mice, stressed by isoflurane anesthesia, than in
control mice, as demonstrated (Figure 1).
Various types of stressors like immobilization, isolation
and open field exploration, which are non-invasive and
should not elicit cytokine production due to tissue
trauma, have been shown to stimulate release of IL-1,
IL-2, IL-4, IL-6 and IFN-γ even before a systemic in-
crease of glucocorticoids [22,39]. On the other hand,
glucocorticoids have been shown to decrease the secre-
tion of IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8, IL-12,
IFN-γ, TNF-α, G-CSF and GM-CSF by inhibiting cyto-
kine mRNA expression and through destabilization of
existing cytokine mRNA [21,40]. Thus, the interaction
between cytokines and a stress response is complex,
and glucocorticoids, depending on the duration and
extent of increased circulating concentrations, may
promote or inhibit cytokine production [23,24].
The stress induced by isoflurane anesthesia in the
present study only appeared to affect G-CSF, where a
modulation of cytokines would have been expected also
for other stress sensitive cytokines like IL-1, IL-6 and
TNF-α [21]. It is possible that the acute stress response
inhibited G-CSF production. However, one should con-
sider the 5% risk of a false positive result (type I error)
given the chosen alpha level in the present study.
Thus, isoflurane anesthesia, although being a potent in-
ducer of the HPA axis, appears not to be a potent effector of
cytokine production. Therefore, we suggest that the use of
short term isoflurane anesthesia for obtaining blood samples
in mice should have little or no impact on cytokines levels.
Conclusion
For the cytokines IL-1α, IL-1β, IL-2, IL-6, IL-9, IL-12p40,
IL-12p70, IL-13, G-CSF, GM-CSF, IFN-γ, KC, MCP-1,
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used as an anticoagulant for obtaining plasma for multi-
plex bead array assays, but an effect of heparin should be
considered for the cytokines IL-9, IL-12p40, IL-12p70,
KC, MCP-1, MIP-1β and RANTES, when heparin is
added in high concentrations. This difference could be
related linearly or exponentially to the amount of hep-
arin added. Although, these correlations could not be
used to accurately determine the true concentration of
cytokines in the sample, the relationships could aid in
calculating a rough estimate for some cytokines. Iso-
flurane anesthesia of short duration had little impact on
the concentrations of cytokines in the present setup.
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